Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy



The aim of this study was to evaluate the usefulness of serum immunoglobulin A/complement factor 3 (IgA/C3) ratio for predicting histological severity of kidney lesions in children with IgA nephropathy (IgAN) based on World Health Organization (WHO) and the Oxford classification (OC).


We studied 89 children with IgAN with a mean age of 11.38 ± 4.1 years (range 2–18 years). Based on available medical records, we retrospectively evaluated clinical data, IgA/C3 ratio, and kidney biopsy findings using the five-grade WHO classification and the OC The mesangial hypercellularity (M), endocapillary hypercellularity (E), segmental sclerosis (S), tubular atrophy/interstitial fibrosis (T) (MEST) score (absent = 0, present = 1) calculated as the sum of M+E+S+T ranging from 0 to 4.


Mean IgA/C3 ratio values were significantly higher (P < 0.05) in patients with M1, S1, and T1 compared with M0, S0, and T0, respectively (P < 0.05); there were no differences in the WHO classification. We found a significant positive correlation between the IgA/C3 ratio and proteinuria (r = 0.24) and determined optimal cutoff values of the IgA/C3 ratio, with a corresponding confidence interval for specific MEST scores.


The IgA/C3 ratio in children with IgAN may be a useful marker of the severity of lesions found in kidney biopsy as evaluated using the OC.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 199

This is the net price. Taxes to be calculated in checkout.

Fig. 1
Fig. 2


  1. 1.

    Coppo R, D’Amico G (2005) Factors predicting progression of IgA nephropaties. J Nephrol 18:503–512

  2. 2.

    Schena FP (1990) A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 89:209–215

  3. 3.

    Berger J, Hinglais N (1968) Intercapillary deposits of IgA-IgG. J Urol Nephrol 74:694–695

  4. 4.

    Yoshikawa N, Iijima K, Matsuyama S, Suzuki J, Kameda A, Okada S, Nakamura H (1990) Repeat renal biopsy in children with IgA nephropathy. Clin Nephrol 33:160–167

  5. 5.

    Galla JH (1995) Perspectives in clinical nephropathy. Kidney Int 47:377–387

  6. 6.

    Yoshikava N, Iijima K, Ito H (1999) IgA nephropathy in children. Nephron 83:1–12

  7. 7.

    Coppo R (2008) Pediatric IgA nephropathy: clinical and therapeutic perspectives. Semin Nephrol 28:18–26

  8. 8.

    Yoshikava N, Tanaka R, Iijima K (2001) Pathophysiology and treatment of IgA nephropathy in children. Pediatr Nephrol 16:446–457

  9. 9.

    Hiemstra PS, Gorter A, Stuurman ME, Van Es LA, Daha MR (1987) Activation of the alternative pathway of complement by human serum IgA. Eur J Immunol 17:321–326

  10. 10.

    Roos A, Rastaldi MP, Calvaresi N, Oortwijn BD, Schlangwein N, van Gijswijk-Jansssen DJ, Stahl GL, Matsushita M, Fujita T, van Kooten C, Daha MR (2006) Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 17:1724–1734

  11. 11.

    Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Eto T (2004) Relationship between serum IgA/C3 ratio and progression of IgA Nephropathy. Intern Med 43:1023–1028

  12. 12.

    Tomino Y (2004) Relationship between the serum IgA/C3 ratio and the progression of IgA nephropathy. Intern Med 43(11):1011

  13. 13.

    Tomino Y, Suzuki S, Imai H, Saito T, Kawamura T, Yorioka N, Harada T, Yosumoto Y, Kida H, Kabayashi Y, Endoh M, Sato H, Saito K (2000) Measurement of serum IgA and C3 may predict the diagnosis of patients with IgA nephropathy prior to renal biopsy. J Clin Lab Anal 14:220–223

  14. 14.

    Davison AM, Cameron JS, Grünfeld JP, Kerr DNS, Ritz E, Winearls CG (1998) IgA nephropaties. Oxford textbook of clinical nephrology. Oxford University Press, p 537–570

  15. 15.

    Lee HS, Kohl HI, Lee HB (1987) IgA nephropathy in Korea: a morphological and clinical Study. Clin Nephrol 27:131–140

  16. 16.

    Haas M (1997) Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 29:829–842

  17. 17.

    Roberts ISD, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D’Agati V, D’Amigo G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jenette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PKT, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2009) The Oxford classification of IgA nephropathy: pathology definitions, correlations and reproducibility. Kidney Int 76:546–556

  18. 18.

    Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637

  19. 19.

    (2005) National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents, Revised version May 2005: Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute; 2005

  20. 20.

    Strzelak K, Koncki R (2013) Nephelometry and turbidimetry with paired emitter detector diodes and their application for determination of total urinary protein. Anal Chim Acta 788:68–73

  21. 21.

    Denhan E, Mohn B, Tucker L, Lun A, Cleave P, Boswell DR (2007) Evaluation of immunoturbidimetric specific protein methods using the Architect ci 8200: comparison with immunonephelometry. Ann Clin Biochem 44:529–536

  22. 22.

    Van der Boog P, Van Kooten C, De Fijter J (2005) Role of macromolecular IgA in IgA nephropathy. Kidney Int 67:813–821

  23. 23.

    Kher KK, Makker SP, Moorthy B (1983) IgA nephroapthy (Berger’s disease). A clinicopathologic study in children. Int J Pediatr Nephrol 4:11–18

  24. 24.

    Wang T, Ye F, Meng H, Zhang L, Jin X (2012) Comparison of clinicopathological features between children and adults with IgA nephropathy. Pediatr Nephrol 27:1293–1300

Download references

Author information

Correspondence to Małgorzata Mizerska-Wasiak.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mizerska-Wasiak, M., Małdyk, J., Rybi-Szumińska, A. et al. Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy. Pediatr Nephrol 30, 1113–1120 (2015).

Download citation


  • IgA nephropathy
  • IgA/C3 serum ratio
  • Oxford classification
  • Renal biopsy
  • Children